Fresita Proteins Limited disclosed the outcome of its Rights Issue Committee meeting held on October 26, 2026, regarding a proposed rights issue of equity shares. The disclosure is made pursuant to Regulations 30 and 42(2) of the SEBI Listing Regulations.
The company received in-principle approval from BSE Limited for the proposed Rights Issue of up to ₹9000.00 lakhs via their letter dated October 8, 2026.
Key Terms of the Rights Issue Approved by the Committee:
Instrument Details:
- Fully paid-up Equity Shares of Face Value of ₹10 each
- Type of Issuance: Rights Issue
Issue Size:
- Total number of Rights Equity Shares: 74,79,917 shares
- Total Issue Size: ₹89,75,90,000 (₹8,975.900 Lakhs) assuming full subscription
Pricing:
- Rights Issue Price: ₹120 per Rights Equity Share (including premium of ₹110 each)
- Payable on application
Entitlement Ratio:
- 5 Rights Equity Shares for every 6 Fully Paid-Up Equity Shares held on the Record Date
Record Date:
- Friday, October 30, 2026 for determining eligible shareholders
ISIN for Rights Entitlement:
- INE995U20011
Rights Issue Schedule:
- Last Date for Credit of Rights Entitlements: Monday, November 2, 2026
- Issue Opening Date: Thursday, November 12, 2026
- Last Date for On-Market Renunciation of REs: Friday, November 20, 2026
- Last Date for Off-Market Renunciation of REs: Wednesday, November 25, 2026
- Issue Closing Date: Thursday, November 26, 2026
- Finalization of Basis of Allotment: Friday, November 27, 2026 (on or about)
- Allotment of Shares: Friday, November 27, 2026 (on or about)
- Credit of Equity Shares: Monday, November 30, 2026 (on or about)
- Listing of Shares: Monday, November 30, 2026 (on or about)
Share Capital Impact:
- Outstanding Equity Shares prior to Rights Issue: 89,75,900 equity shares
- Outstanding Equity Shares post Rights Issue (assuming full subscription): 1,64,55,817 equity shares
The Board of Directors adopted the Letter of Offer to be filed with BSE Limited, which will be dispatched to eligible shareholders on the Record Date.
The meeting of the Rights Issue Committee commenced at 5:30 PM and concluded at 6:30 PM on October 26, 2026.
Annexure-A provides additional details as required under Regulation 30 of the Listing Regulations read with SEBI circular SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, confirming:
- Type of Securities: Equity Shares
- Type of Issuance: Rights Shares
- Total number: Up to 74,79,917 Right Equity Shares of face value of ₹10 each issued at ₹120 each aggregating up to ₹89,75,90,000 (assuming full subscription)